Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1372 of 5804
-
Brain bleed breakthrough? drug may stop deadly vessel spasms
Disease control CompletedThe aim of this study is to evaluate the role of intraoperative dexmedetomidine infusion in endovascular intervention for aneurysmal subarachnoid hemorrhage.
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug could shield preemie lungs from chronic disease
Prevention CompletedThe purpose of this study is to identify the safest dose of recombinant surfactant protein D (drug name: rfhSP-D) that can be administered to preterm infants born at less than 30 weeks gestation, and to help identify whether this can prevent the development of neonatal chronic lu…
Phase: PHASE1 • Sponsor: University College, London • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC
-
Gene therapy vs. cochlear implants: which restores hearing better?
Knowledge-focused Recruiting nowThis cohort study aims to explore the trends and differences in multidimensional perceptual levels of patients after cochlear implants or gene therapy, as well as to comprehensively assess the efficacy of gene therapy for congenital deafness, thus providing a reference for making…
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:14 UTC
-
Gel patch mends eardrums without surgery – new study shows promise
Disease control CompletedThe purpose of the study is to assess the effectiveness of Perf-Fix as a gel patch to aid in the natural healing process to close chronic, \>25% tympanic membrane perforation.
Phase: NA • Sponsor: Tympanogen • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a diabetes drug protect transplanted kidneys? new study aims to find out
Disease control Recruiting nowKidney transplantation improves the health and quality of life for those Veterans with end stage kidney disease (ESKD). While early patient and graft survival are excellent, long-term outcomes continue to be challenging. Patient death with existing kidney graft function occurs in…
Phase: PHASE4 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Nerve block combo calms brain injury storms
Symptom relief CompletedNeurostorming is a sudden and exaggerated stress response as a result of damage to the brain. With appropriate treatment and time, there is hope for individuals to overcome storming, regain consciousness, and work towards successfully recovering from brain injury. Most treatments…
Phase: NA • Sponsor: Zagazig University • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
AI could spot heart transplant rejection without a biopsy
Diagnosis Recruiting nowThe purpose of this research is to detect episodes of rejection versus non-rejection after cardiac transplant and the diagnostic accuracy of an Artificial Intelligence (AI) algorithm using the data from an ECG (electrocardiogram) and Cardiac Ultrasound (Echocardiogram and/or poin…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
New hope for lung scarring? trial of GSK3915393 cut short
Disease control TerminatedIdiopathic Pulmonary Fibrosis is a chronic lung disease which causes scarring of the lungs and difficulty in breathing. GSK3915393 is a new medicine, which is being tested in participants with IPF for the first time. The study will assess the safety and effectiveness of GSK391539…
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New hope for transplant patients: easier CMV prevention on the horizon?
Disease control Recruiting nowOpen label study to determine tolerability and efficacy of letermovir for CMV prophylaxis in heart and lung transplant recipients. The study hypotheses are: 1. Letermovir prophylaxis will be associated with similar rates of CMV infection as valganciclovir among heart and lung tr…
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Mom's voice might wake coma patients better than nature sounds
Symptom relief CompletedThe goal of this clinical trial is to compare the effectiveness of auditory stimulation using familiar voices (FV) versus nature sounds (NS) on awakening critically ill comatose persons in the intensive care unit (ICU), reduce pain and stabilize their physiological parameters. Th…
Phase: NA • Sponsor: Vo Thi Hong Nhan • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New pill shows promise for Hard-to-Treat ovarian cancer
Disease control OngoingThis is a randomized, phase 1b study to assess the safety, tolerability, pharmacokinetics (PK), and efficacy of sovilnesib at different dose levels to establish the Recommended Phase 2 Dose (RP2D) of sovilnesib in subjects with high grade serous ovarian cancer (HGSOC).
Phase: PHASE1 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug TPST-1495 tested in cancer patients before surgery
Disease control OngoingThe proposed clinical trial with TPST-1495 can help people with two types of cancer, Endometrial Cancer (EC) and Colorectal Carcinoma (CRC), who need surgery. The investigator plans to evaluate how well TPST-1495 works against these cancers by checking blood samples and tumor tis…
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Immune cell therapy shows promise for tough lupus cases
Disease control OngoingAB-101 (also known as AlloNK) is an off-the shelf, allogeneic cell product made of "natural killer" cells, also called NK cells. White blood cells are part of the immune system and NK cells are a type of white blood cell that is known to enhance the effect of monoclonal antibody …
Phase: PHASE1 • Sponsor: Artiva Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New RNA drug takes aim at tough bladder cancer
Disease control Recruiting nowThis is an open label, multi-center study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of RAG-01 in patients with NMIBC who have failed BCG therapy.
Phase: PHASE1 • Sponsor: Ractigen Therapeutics. • Aim: Disease control
Last updated Jun 26, 2026 15:24 UTC
-
Could freezing tumors replace surgery for some breast cancers?
Disease control Recruiting nowThis trial studies the efficacy and safety of cryoablation in patients with low risk, early stage breast cancer. Cryoablation is a method of killing a tumor by freezing it. The standard approach for patients with this kind of cancer is a lumpectomy. This study will review the saf…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Brain implant aims to quiet voices in Drug-Resistant schizophrenia
Disease control Recruiting nowThere are three hypotheses proposed for this study: 1) Participants will report no unanticipated serious adverse events during the eight months of treatment. 2) Investigators will successfully model psychotic versus non-psychotic brain states using support vector machine (SVM) cl…
Phase: NA • Sponsor: Bradley Lega • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New inhaled therapy aims to slow lung scarring in progressive fibrosis
Disease control OngoingA randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of 2 doses of inhaled pirfenidone (AP01) versus placebo on top of standard of care in participants with PPF over 52 weeks.
Phase: PHASE2 • Sponsor: Avalyn Pharma Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for Hard-to-Treat cancers? early trial launches
Disease control Recruiting nowThe purpose of this first-in-human study, CTMX-2051-101, is to characterize the safety, tolerability, and antitumor activity of CX-2051 as a monotherapy and in combination with bevacizumab in adult participants with advanced solid tumors.
Phase: PHASE1 • Sponsor: CytomX Therapeutics • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New blood test aims to spot lyme disease in kids faster and more accurately
Diagnosis Recruiting nowThe investigators propose a single center, prospective observational study in children with Lyme disease (LD), the Borrelia B-cell diagnostics (BRILLIANT) study, to assess the immune response against Borrelia burgdorferi (Bb) with the following main objectives: 1. Development of…
Sponsor: University Children's Hospital, Zurich • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
New drug aims to spare cancer patients from debilitating mouth sores
Symptom relief OngoingThe purpose of this study is to determine if RRx-001, which is added on to the cisplatin and radiation treatment, reduces the incidence of severe oral mucositis in patients with head and neck cancers. All patients in this study will receive 7 weeks of standard of care radiation t…
Phase: PHASE2 • Sponsor: EpicentRx, Inc. • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC